BHVN's Troriluzole awaits pivotal FDA approval in 2025, backed by $600M funding. Explore its diverse pipeline and promising ...

Mesoblast Limited’s FDA-approved Ryoncil and advancing Revascor target major conditions like SR-aGVHD and heart failure. See ...

"Among the fastest growing parts of the market is wealthy homeowners with sufficient levels of income but concerns ... to provide the right environment, diet and care for the animal to ensure ...